Abnormal levels and minimal activity of the dsRNA-activated protein kinase, PKR, in breast carcinoma cells

International Journal of Biochemistry and Cell Biology

Volumn 31, Issue 1, 1999, Pages 175-189

  Savinova, Olga ^a,b   Joshi, Bhavesh ^a   Jagus, Rosemary ^a,c  

^a UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE   (United States)

^b JACKSON LABORATORY   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

Author keywords

Apoptosis; Breast cancer; PKR; Translational regulation

Indexed keywords

DOUBLE STRANDED RNA; HEPARIN; INITIATION FACTOR 2; INTERFERON; PROTEIN INHIBITOR; PROTEIN KINASE;

APOPTOSIS; ARTICLE; BREAST CARCINOMA; BREAST DUCT; CANCER CELL; CELL PROLIFERATION; CELL TRANSFORMATION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOLOGICAL PROCEDURES; PROTEIN PHOSPHORYLATION; PROTEIN PURIFICATION; PROTEIN RNA BINDING; TRANSLATION INITIATION; TRANSLATION REGULATION;

BREAST; BREAST NEOPLASMS; CELL EXTRACTS; CYTOPLASM; EIF-2 KINASE; ENZYME ACTIVATION; EUKARYOTIC INITIATION FACTOR-2; FEMALE; HELA CELLS; HEPARIN; HUMANS; INTERFERON-BETA; PHOSPHORYLATION; POLY C; POLY I; TUMOR CELLS, CULTURED;

EID: 0032967979     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(98)00140-X     Document Type: Article

References (88)

1. M.J. Clemens, A. Elia, The double-stranded RNA-dependent protein kinase PKR: structure and function, J. Interferon Cytokine Res. 17 (1997) 503-524.
2. H.D. Robertson, M.B. Mathews, The regulation of the protein kinase PKR by RNA, Biochimie 78 (1996) 909-914.
3. V.M. Pain, Initiation of protein synthesis in eukaryotic cells, Eur. J. Biochem. 236 (1996) 747-771.
4. C. DeHaro, The eIF2α kinases and the control of protein synthesis, FASEB J. 10 (1996) 1378-1387.
5. S.B. Lee, M. Esteban, The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis, Virol. 199 (1994) 491-496.
6. S.B. Lee, D. Rodriguez, J.R. Rodriguez, M. Esteban, The apoptosis pathway triggered by the interferon-induced protein kinase, PKR, requires the third basic domain, initiates upstream of Bcl-2, and involves ICE-like proteases, Virology 231 (1997) 81-88.
7. S.D. Der, Y.L. Yang, C. Weissman, B.R. Williams, A dsRNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis, Proc. Natl. Acad. Sci. 94 (1997) 3279-3283.
8. S.P. Srivastava, K.U. Kumar, R.J. Kaufman, Phosphorylation of eIF2 mediates apoptosis in response to activation of PKR, J. Biol. Chem. 273 (1998) 2416-2423.
9. S. Balachandran, N. Kim, W.-C. Yeh, T.W. Mak, K. Bhalla, G.N. Barber, Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis and employs the death signal transducer FADD. EMBO J., in press.
10. R. Jagus, B. Joshi, G.N. Barber, PKR, apoptosis and cancer. Int. J. Biochem. Cell Biol., 31 (1999) 123-138.
11. A.E. Koromilas, S. Roy, G.N. Barber, M. Katze, N. Sonenberg, Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase, Science 257 (1992) 1685-1689.
12. E. Meurs, J. Galabru, G.N. Barber, M.G. Katze, A.G. Hovanessian, Interferon-induced dsRNA activated protein kinase: antiviral and antitumoral functions, Proc. Natl. Acad. Sci. 90 (1993) 232-236.
13. G. Barber, M. Wambach, S. Thompson, R. Jagus, M.G. Katze, Mutants of PKR lacking dsRNA binding domain I can act as transdominant inhibitors and induce malignant transformation, Mol. Cell. Biol. 15 (1995) 3138-3146.
14. G.N. Barber, R. Jagus, E.F. Meurs, A. Hovanessian, M.G. Katze, Molecular mechanisms responsible for malignant transformation by regulatory and catalytic domain variants of PKR, J. Biol. Chem. 270 (1995) 17423-17428.
15. G.N. Barber, S. Thompson, T.G. Lee, T. Strom, R. Jagus, A. Darveau, M.G. Katze, The 58-kDa inhibitor of PKR is a TPR protein with oncogenic properties, Proc. Natl. Acad. Sci. 91 (1994) 4278-4282.
16. O. Donze, R. Jagus, A.E. Koromilas, J.W.B. Hershey, N. Sonenberg, Abrogation of translation initiation factor eIF-2 phosphorylation, EMBO J. 14 (1995) 3828-3834.
17. Y.-L. Yang, L.F.L. Reis, J. Pavlovic, A. Aguzzi, R. Schafer, A. Kumar, B.R.G. Williams, M. Aguet, C. Weissman, Deficient signaling in mice devoid of dsRNA-dependent protein kinase (PKR), EMBO J. 14 (1995) 6095-6106.
18. C. Deng, P. Zhang, J.W. Harper, S.J. Elledge, P. Leder, Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control, Cell 82 (1995) 675-684.
19. J.W. Harper, Cyclin dependent kinase inhibitors, Cancer Surv. 29 (1997) 91-107.
20. M. Peter, The regulation of cyclin-dependent kinase inhibitors (CKIs), Progr. Cell Cycle Res. 3 (1997) 99-108.
21. C. Missero, F. Di Cunto, H. Kiyokawa, A. Koff, G.P. Dotto, The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression, Genes Dev. 10 (1996) 3065-3075.
22. J. Yokota, T. Sugimura, Multiple steps in carcinogenesis involving alterations of multiple tumor suppressor genes, FASEB J. 7 (1993) 920-925.
23. G.K. Haines, G. Ghadge, J.A. Radosevich, Expression of p68 protein kinase as recognized by the monoclonal antibody TJ4C4 during human fetal development, Tumor Biol. 14 (1993) 95-104.
24. G.K. Haines, G.D. Ghadge, B. Thimmapaya, J.A. Radosevich, Expression of PKR (p68) recognized by the monoclonal antibody TJ4C4 in human lung neoplasms, Virch. Arch. B Cell Pathol. 62 (1992) 151-158.
25. G.K. Haines, S. Becker, G. Ghadge, M. Kies, H. Pelzer, J.A. Radosevich, Expression of PKR(p68) in squamous cell carcinoma of the head and neck region, Arch. Otolaryngol. Head Neck Surg. 119 (1993) 1142-1147.
26. G.K. Haines, G.D. Ghadge, S. Becker, M. Kies, H. Pelzer, B. Thimmapaya, J.A. Radosevich, Correlation of the expression of PKR (p68) with differentiation in head and neck squamous cell carcinoma, Virch. Arch. B Cell Pathol. 63 (1993) 289-295.
27. A. Vojdani, M. Ghoneum, P.C. Choppa, L. Magtoto, C.W. Lapp, Elevated apoptotic cell population in patients with chronic fatigue syndrome: the pivotal role of protein kinase RNA, J. Intern. Med. 242 (1997) 465-478.
28. C. Singh, G.K. Haines, M.S. Talamonti, J.A. Radosevich, Expression of p68 (PKR) in human colon cancer, Tumor Biol. 16 (1995) 281-289.
29. G.K. Haines, R.J. Panos, P.M. Bak, T. Brown, M. Zielinski, J. Leyland, J.A. Radosevich, Interferon-responsive protein kinase (p68) and proliferating cell nuclear antigen are inversely distributed in head and neck squamous cell carcinoma, Tumor Biol. 19 (1998) 52-59.
30. G.K. Haines, R. Cajulis, R. Hayden, R. Duda, M. Talamonti, J.A. Radosevich, Expression of p68 (PKR) in human breast tissues, Tumor Biol. 17 (1996) 5-12.
31. H.D. Soule, T.M. Maloney, S.R. Wolman, W.D. Peterson, R. Brenz, C.M. McGrath, J. Russo, R.J. Pauley, R.F. Jones, S.C. Brooks, Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10, Cancer Res. 50 (1990) 6075-6086.
32. B. Krust, J. Galabru, A.G. Hovanessian, Further characterization of the protein kinase activity mediated by interferon in mouse and human cells, J. Biol. Chem. 259 (1984) 8494-8498.
33. K.A. Scorsone, R. Panniers, A.G. Rowlands, E.C. Henshaw, Phosphorylation of eIF-2 during physiological stresses which affect protein synthesis, J. Biol. Chem. 262 (1987) 14538-14543.
34. M.G. Katze, J. Tomita, T. Black, B. Safer, A.G. Hovanessian, Influenza virus regulates protein synthesis by repressing the autophosphorylation of PKR, J. Virol. 62 (1988) 3710-3717.
35. K. Carroll, O. Elroy-Stein, B. Moss, R. Jagus, Recombinant vaccinia virus K3L gene product prevents activation of double-stranded RNA-dependent initiation factor 2 alpha-specific protein kinase, J. Biol. Chem. 268 (1993) 12837-12842.
36. T.L. Black, B. Safer, A.G. Hovanessian, M.G. Katze, Cellular PKR is highly phosphorylated and activated yet significantly degraded during polio virus infection, J. Virol. 63 (1989) 2244-2251.
37. A. Konieczny, B. Safer, Purification of eIF-2:eIF-2B complex and its nucleotide exchange activity, J. Biol. Chem. 258 (1982) 3402-3408.
38. O. Savinova, R. Jagus, Use of vertical slab gel isoelectric focusing and immunoblotting to evaluate steady state levels of eIF2α phosphorylation in cells, Methods 11 (1997) 419-425.
39. Y. Miyagi, A. Sugiyama, A. Asai, T. Okazaki, Y. Kuchino, S.J. Kerr, Elevated levels of eIF4E mRNA in a broad spectrum of transformed cell lines, Cancer Lett. 91 (1995) 247-252.
40. I.B. Rosenwald, D.B. Rhoads, L.D. Callanan, K.J. Isselbacher, E.V. Schmidt, Increased expression of eukaryotic initiation factors eIF-4E and eIF-2α in response to growth induction by c-myc, Proc. Natl. Acad. Sci. 90 (1993) 6175-6178.
41. I.B. Rosenwald, Deregulation of protein synthesis as a mechanism of neoplastic transformation, BioEssays 18 (1996) 243-250.
42. I.B. Rosenwald, Upregulated expression of the genes encoding eIF4E and eIF2α in transformed cells, Cancer Lett. 102 (1996) 113-123.
43. B. Raught, A.-C. Gingras, A. James, D. Medina, N. Sonenberg, J.M. Rosen, Expression of a translationally regulated, dominant-negative C/EBPβ isoform and upregulation of eIF2α are correlated with neoplastic transformation of mammary epithelial cells, Cancer Lett. 59 (1996) 4382-4386.
44. R.P. Shiu, P.H. Watson, D. Dubik, c-myc oncogene expression in estrogen-dependent and -independent breast cancer, Clin. Chem. 39 (1993) 353-355.
45. B.J. Efiok, J.A. Chiorini, B. Safer, A key transcription factor for eIF2α is strongly homologous to developmental transcription factors and may link metabolic genes to cellular growth and development, J. Biol. Chem. 269 (1994) 18921-18930.
46. I.W. Jeffrey, S. Kadereit, T. Metzger, M. Bachmann, M. Scwemmle, A.G. Hovanessian, M.J. Clemens, Nuclear localization of PKR in human cells and transfected mouse cells, Exp. Cell Res. 218 (1995) 17-27.
47. S. Swaminathan, P. Rajan, O. Savinova, R. Jagus, B. Thimmapaya, SV40 large-T antigen bypasses the translational block imposed by the phosphorylation of eIF2α, Virology 219 (1996) 321-323.
48. A. Koromilas, C. Cantin, A. Craig, R. Jagus, J. Hiscott, N. Sonenberg, The interferon-inducible protein kinase, PKR, mediates the transcriptional activation of the immunoglobulin κ gene, J. Biol. Chem. 270 (1995) 25426-25434.
49. M.K. Offerman, J. Zimring, K.H. Mellits, M.K. Hagan, R. Shaw, R.M. Medford, M.B. Mathews, S. Goodbourn, R. Jagus, Activation of PKR and induction of vascular cell adhesion molecule-1 by dsRNA in endothelial cells, Eur. J. Biochem. 232 (1995) 28-36.
50. V. Kolla, D.J. Lindner, W. Xiao, E.C. Borden, D.V. Kalvakolanu, Modulations of IFN-inducible gene expression by retinoic acid: upregulation of STAT1 in IFN-unresponsive cells, J. Biol. Chem. 271 (1996) 10508-10514.
51. L.J. Ransome, A. Dasgupta, A heat-sensitive inhibitor in poliovirus-infected cells which selectively blocks phosphorylation of eIF-2α by PKR, J. Virol. 62 (1988) 3551-3557.
52. E. Meurs, K. Chong, J. Galabru, N.S. Thomas, I.M. Kerr, B.R.G. Williams, A.G. Hovanessian, Molecular cloning and characterization of the double-stranded, RNA-activated protein kinase induced by interferon, Cell 62 (1990) 379-390
53. K. Mellits, M.B. Mathews, Effects of mutations in stem and loop regions on the structure and function of adenovirus VA RNA, EMBO J. 7 (1988) 2849-2859.
54. G.N. Barber, T. Tomita, A.G. Hovanessian, E. Meurs, M.G. Katze, Functional expression and characterization of interferon-induced double-stranded RNA activated P68 protein kinase from Escherichia coli, Biochem. 30 (1991) 10356-10361.
55. K.H. Mellits, M. Kostura, M.B. Mathews, Interaction of adenovirus VAI RNA with PKR: nonequivalence of binding and function, Cell 61 (1990) 843-852.
56. T.V. Sharp, Q. Xiao, D.R. Gewert, M.J. Clemens, Comparative analysis of the regulation of PKR by Epstein-Barr virus RNAs, EBER-1 and EBER-2 and adenovirus VA1 RNA, Nucleic Acids Res. 21 (1993) 4483-4489.
57. K.H. Mellits, T. Pe'ery, M.B. Mathews, Role of the apical stem in maintaining structure and function of adenovirus-associated RNAs, J. Virol. 66 (1992) 2369-2377.
58. M.G. Katze, Games viruses play: a strategic initiative against PKR, Seminars Virol. 4 (1993) 259-268.
59. R. Jagus, M.E. Gray, Proteins that interact with PKR, Biochimie 76 (1994) 779-791.
60. B.L. Jacobs, J.O. Langland, When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA, Virology 219 (1996) 339-349.
61. T.G. Lee, J. Tomita, A.G. Hovanessian, M.G. Katze, Purification and partial characterization of an inhibitor of PKR during influenza virus infection, Proc. Natl. Acad. Sci. 87 (1990) 6208-6212.
62. T.G. Lee, J. Tomita, A.G. Hovanessian, M.G. Katze, Characterization and regulation of the 58 kDa cellular inhibitor of PKR, J. Biol. Chem. 267 (1992) 14238-14243.
63. T.G. Lee, M.G. Katze, Cellular inhibitors of PKR, Progr. Mol. Subcel. Biol. 14 (1993) 48-65.
64. T.G. Lee, N. Tang, S. Thompson, J. Miller, M.G. Katze, The 58-kDa cellular inhibitor of PKR is a member of the TPR family of proteins, Mol. Cell. Biol. 14 (1994) 2331-2342.
65. M. Gale, S.L. Tan, M. Wambach, M.G. Katze, Interaction of the interferon-induced kinase, PKR, with inhibitory proteins p58 and vaccinia virus K3L is mediated by unique domains -implications for kinase function, Mol. Cell. Biol. 16 (1996) 4172-4181.
66. M.W. Melville, W.J. Hansen, B.C. Freeman, W.J. Welch, M.G. Katze, The molecular chaperone hsp40 regulates the activity of p58, the cellular inhibitor of PKR, Proc. Natl. Acad. Sci. 94 (1997) 97-102.
67. M. Gale, C.M. Blakely, D.A. Hopkins, M.W. Melville, M. Wambach, P.R. Romano, M.G. Katze, Regulation of interferon-induced protein kinase PKR: modulation of P58IPK inhibitory function by a novel protein, P52rIPK, Mol. Cell. Biol. 18 (1998) 859-871.
68. M.K. Ray, B. Datta, A. Chakraborty, A. Chattopadhyay, S. Meza-Keuthen, N.K. Gupta, The eIF2-associated 67-kDa polypeptide (p67) plays a critical role in the regulation of protein synthesis in animal cells, Proc. Natl. Acad. Sci. 89 (1992) 539-543.
69. R. Judware, R. Petryshyn, Partial characterization of a cellular factor that regulates dsRNA-dependent eIF-2α kinase in 3T3-F442A fibroblasts, Mol. Cell. Biol. 11 (1991) 3259-3267.
70. R. Judware, R. Petryshyn, Mechanism of action of a cellular inhibitor of the dsRNA-dependent protein kinase from 3T3-F442A cells, J. Biol. Chem. 267 (1992) 21685-21690.
71. S. Saito, M. Kawakita, Inhibitor of interferon-induced dsRNA-dependent protein kinase, Microbiol. Immunol. 35 (1991) 1105-1114.
72. S. Saito, Enhancement of the interferon-induced dsRNA-dependent protein kinase by Sindbis virus infection and heat-shock stress, Microbiol. Immunol. 34 (1990) 859-870.
73. L.J. Mundschau, D.V. Faller, Oncogenic ras induces inhibition of PKR, J. Biol. Chem. 267 (1992) 23092-23098.
74. L.J. Mundschau, D.V. Faller, Endogenous inhibitors of PKR in normal and ras transformed cells, Biochimie 76 (1994) 792-800.
75. T. Ito, R. Jagus, S. May, IL-3 stimulates protein synthesis by regulating dsRNA-dependent protein kinase (PKR), Proc. Natl. Acad. Sci. 91 (1994) 7455-7459.
76. L. Hengst, S.I. Reed, Translational control of p27Kip1 accumulation during the cell cycle, Science 271 (1996) 1861-1864.
77. S.S. Millard, J.S. Yan, H. Nguyen, M. Pagano, H. Kiyokawa, A. Koff, Enhanced ribosomal association of p27(Kip1) mRNA is a mechanism contributing to accumulation during growth arrest, J. Biol. Chem. 272 (1997) 7093-7098.
78. V. Dulic, S. Lee, S. Reed, Association of human cyclin E with a periodic G1-S phase protein kinase, Science 257 (1992) 1958-1961.
79. C.J. Sherr, J.M. Roberts, Inhibitors of mammalian G1 cyclin-dependent kinases, Genes Dev. 9 (1995) 1149-1163.
80. C. Catzavelos, N. Bhattacharya, Y.C. Ung, J.A. Wilson, L. Roncari, C. Sandhu, P. Shaw, H. Yeger, I. Morava-Protzner, L. Kaputsa, E. Franssen, K.I. Pritchard, J.M. Slingerland, Decreased levels of the cell cycle inhibitor p27: prognostic implications in primary breast cancer, Nature Med. 3 (1997) 227-230.
81. P.L. Porter, K.E. Malone, P.J. Heagerty, G. M. Alexander, L.A. Gatti, E.J. Firpo, J.R. Daling, J.M. Roberts, Expression of cell cycle regulators p27 and cyclin E, alone or in combination, correlate with survival in young breast cancer patients, Nature Med. 3 (1997) 222-225.
82. C.A. Zahnow, P. Younes, R. Laucirica, J.M. Rosen, Overexpression of C/EBPbeta-LIP, a naturally occurring, dominant-negative transcription factor, in human breast cancer, J. Natl. Cancer Inst. 89 (1997) 1887-1891
83. C.A. Zahnow, P. Younes, R. Laucirica, J.M. Rosen, Overexpression of C/EBPbeta-LIP, a naturally occurring, dominant-negative transcription factor, in human breast cancer, J. Natl. Cancer Inst. 89 (1997) 1887-1891.
84. M. Buck, H. Turler, M. Chojkier, LAP (NF-IL-6), a tissue-specific transcriptional activator, is an inhibitor of hepatoma cell proliferation, EMBO J. 13 (1994) 851-860.
85. R.C. Bargou, P.T. Daniel, M.Y. Mapara, K. Bommert, C. Wagener, B. Kallinich, H.D. Royer, B. Dorken, Expression of bcl-2 family in normal and malignant breast tissue, Int. J. Cancer 60 (1995) 854-859.
86. S. Krajewski, C. Blomqvist, K. Franssila, M. Krajewska, V.M. Wasenius, E. Niskanen, S. Nordling, J.C. Reed, Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma, Cancer Res. 55 (1995) 4471-4478.
87. A.G. Hinnebusch, Translational regulation of yeast GCN4. A window on factors that control initiator-tRNA binding to the ribosome, J. Biol. Chem. 272 (1997) 21661-21664.
88. J.C. Reed, Balancing cell life and death: bax, apoptosis and breast cancer, J. Clin. Invest. 97 (1996) 2403-2404.